Congleton Jon
Reporting owner on Forms 3, 4 and 5, CIK 1644975.
Congleton Jon reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-02.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Mineralys Therapeutics, Inc. CIK 1933414 | director, officer (Chief Executive Officer) | 1 | 2026-10-02 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Mineralys Therapeutics, Inc. Common Stock | 2026-09-30 | S sold | -75,000 | $25.4622 | 528,621 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001933414-26-000121 | Mineralys Therapeutics, Inc. | 2026-10-02 |